cipla
Cipla Launches Hepatitis B Vaccine In India
Cipla’s hepatitis B vaccine can prevent 95 percent of the recipients from developing a chronic infection, protecting them for decades.
Cipla Strengthens Presence In US Market
The UK arm of India-based pharmaceutical Cipla has acquired two US-based companies to further their reach in that region.
Cipla Expands Into The US With InvaGen & Exelan Acquistions
Cipla grows its portfolio by acquiring InvaGen and Exelan Pharmaceuticals, stretching its reach to the US market.
FDA Approval For Cipla’s Child-Friendly HIV Drug Formulation
A novel pediatric formulation of anti-retroviral drugs could be life saving for children living with HIV.
Stem Cell-Based Drug Granted Chinese Patent
The bone marrow-based drug is indicated for the treatment of critical limb ischemia, a common complication of diabetes.
WHO Prequalifies Indian Malaria Drug
A new artemisinin-based malaria drug produced by Indian pharmaceutical company Cipla has been prequalified by the World Health Organization (WHO).
OPINION: India Mustn’t Bow To Patent Pressure
The latest round of challenges to India's drug patent laws is a fight that must be won for the world's poor, says Priya Shetty.
